Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ballinger, 1992, Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion, Nat. Genet., 1, 11, 10.1038/ng0492-11
Barthel, 2003, Novel concepts in insulin regulation of hepatic gluconeogenesis, Am. J. Physiol., 285, E685
Basta, 2004, Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes, Cardiovasc. Res., 63, 582, 10.1016/j.cardiores.2004.05.001
Bodrova, 1998, Membrane potential generation coupled to oxidation of external NADH in liver mitochondria, FEBS Lett., 435, 269, 10.1016/S0014-5793(98)01072-2
Bolton, 2004, Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy, Am. J. Nephrol., 24, 32, 10.1159/000075627
Boss, 2000, Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism, Diabetes, 49, 143, 10.2337/diabetes.49.2.143
Bonnefont-Rousselot, 2002, Glucose and reactive oxygen species, Curr. Opin. Clin. Nutr. Metab. Care, 5, 561, 10.1097/00075197-200209000-00016
Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a
Brownlee, 2003, A radical explanation for glucose-induced β-cell dysfunction, J. Clin. Invest., 112, 1788, 10.1172/JCI200320501
Camirand, 1998, Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle, Endocrinology, 139, 428, 10.1210/en.139.1.428
Carley, 2005, Fatty acid metabolism is enhanced in type 2 diabetic hearts, Biochim. Biophys. Acta, 1734, 112, 10.1016/j.bbalip.2005.03.005
Ceriello, 2003, New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy, Diabetes Care, 26, 1589, 10.2337/diacare.26.5.1589
Cooper, 2004, Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease, Am. J. Hypertens., 17, 31S, 10.1016/j.amjhyper.2004.08.021
Claudel, 2005, The farnesoid X receptor. A molecular link between bile acid and lipid and glucose homeostasis, Arterioscler., Thromb., Vasc. Biol., 25, 2020, 10.1161/01.ATV.0000178994.21828.a7
De Fabiani, 2004, Bile acid signaling to the nucleus: finding new connections in the transcriptional regulation of metabolic pathways, Biochimie, 86, 771, 10.1016/j.biochi.2004.09.027
Du, 2000, Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp 1 glycosylation, Proc. Natl. Acad. Sci. U.S.A., 97, 12222, 10.1073/pnas.97.22.12222
Dufour, 2004, Understanding aging: revealing order out of chaos, Biochim. Biophys. Acta, 1658, 122, 10.1016/j.bbabio.2004.04.020
Dullo, 2001, Uncoupling proteins: their roles in adaptive thermogenesis and substrate metabolism reconsidered, Br. J. Nutr., 86, 123, 10.1079/BJN2001412
Duran-Sandoval, 2005, Potential regulatory role of the farnesoid X receptor in the metabolic syndrome, Biochimie, 87, 93, 10.1016/j.biochi.2004.11.018
Evans, 2003, Are oxidative stress-activated signaling pathways mediators en insulin resistance and β-cell dysfunction?, Diabetes, 52, 1, 10.2337/diabetes.52.1.1
Ferreira, 1999, Decreased susceptibility to lipid peroxidation of Goto–Kakizaki rats: relationship to mitochondrial antioxidant capacity, Life Sci., 65, 1013, 10.1016/S0024-3205(99)00332-X
Ferreira, 1999, Age-related alterations in liver mitochondrial bioenergetics of diabetic Goto–Kakizaki rats, Acta Diabetol., 36, 173, 10.1007/s005920050163
Ferreira, 2003, Diabetes and mitochondrial bioenergetics: alterations with age, J. Biochem. Mol. Toxicol., 17, 214, 10.1002/jbt.10081
Fukui, 2000, A new thiazolidinedione, NC-2100, which is a weak PPARγ-activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice, Diabetes, 4, 759, 10.2337/diabetes.49.5.759
Gabriely, 2002, Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway, Atherosclerosis, 160, 115, 10.1016/S0021-9150(01)00574-3
Giardino, 1996, BCL-2 expression or antioxidants prevent hyperglycemia induced formation of intracellular advanced glycation endproducts in bovine endothelial cells, J. Clin. Invest., 97, 1422, 10.1172/JCI118563
Goldberg, 2002, The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-′βI and -′δ, J. Biol. Chem., 277, 33833, 10.1074/jbc.M112331200
Green, 2004, Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes, Diabetes, 53, S110, 10.2337/diabetes.53.2007.S110
Ha, 2000, Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose, Kidney Int., 58, S19, 10.1046/j.1523-1755.2000.07704.x
Hammarstedt, 2003, Thiazolidinediones (PPAR gamma ligands) increase IRS-1, UCP-2 and C/EBPalpha expression, but not transdifferentiation, in L6 muscle cells, Diabetologia, 46, 48, 10.1007/s00125-002-1002-7
Hammarstedt, 2003, Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance, Biochem. Biophys. Res. Commun., 301, 578, 10.1016/S0006-291X(03)00014-7
Hammes, 1991, Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy, Proc. Natl. Acad. Sci. U.S.A., 88, 11555, 10.1073/pnas.88.24.11555
Han, 2004, UCP-mediated energy depletion in skeletal muscle increases glucose transport despite lipid accumulation and mitochondrial dysfunction, Am. J. Physiol.: Endocrinol. Metab., 286, E347, 10.1152/ajpendo.00434.2003
Hojlund, 2003, Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes, J. Biol. Chem., 278, 10436, 10.1074/jbc.M212881200
Huss, 2005, Mitochondrial energy metabolism in heart failure: a question of balance, J. Clin. Invest., 115, 547, 10.1172/JCI24405
Ishigaki, 2005, Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity, Diabetes, 54, 322, 10.2337/diabetes.54.2.322
Ito, 2004, PPARγ overexpression selectively suppresses insulin secretory capacity in isolated pancreatic islets through induction of UCP-2 protein, Biochem. Biophys. Res. Commun., 324, 810, 10.1016/j.bbrc.2004.08.238
James, 2002, Flux through the hexosamine pathway is a determinant of nuclear factor κB-dependent promoter activation, Diabetes, 51, 1146, 10.2337/diabetes.51.4.1146
Krauss, 2003, Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction, J. Clin. Invest., 112, 1831, 10.1172/JCI200319774
Kelly, 2004, Transcriptional regulatory circuits controlling mitochondrial biogenesis and function, Genes Dev., 18, 357, 10.1101/gad.1177604
Kelly, 1998, Peroxisome proliferator-activated receptors γ and γ mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression, Endocrinology, 139, 4920, 10.1210/en.139.12.4920
Kota, 2005, An overview on biological mechanisms of PPARs, Pharmacol. Res., 51, 85, 10.1016/j.phrs.2004.07.012
King, 1998, Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections, Diabetes Care, 21, 1414, 10.2337/diacare.21.9.1414
Korshunov, 1997, High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria, FEBS Lett., 416, 15, 10.1016/S0014-5793(97)01159-9
Lambert, 2004, Inhibitors of the quinone binding site allow rapid superoxide production from mitochondrial NADH: ubiquinone oxidoreductase (complex I), J. Biol. Chem., 279, 39414, 10.1074/jbc.M406576200
Lambert, 2004, Superoxide production by NADH: ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane, Biochem. J., 382, 511, 10.1042/BJ20040485
Lamson, 2002, Mitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment, Altern. Med. Rev., 7, 94
Langin, 2003, The role of uncoupling protein 2 in the development of type 2 diabetes, Drugs Today (Barc.), 39, 287, 10.1358/dot.2003.39.4.737960
Lee, 1998, Decreased mitochondrial DNA content in peripheral blood precedes the development of non-insulin-dependent diabetes mellitus, Diabetes Res. Clin. Pract., 42, 161, 10.1016/S0168-8227(98)00110-7
Li, 2001, Uncoupling protein-2 participates in cellular defense against oxidative stress in clonal beta-cells, Biochem. Biophys. Res. Commun., 282, 273, 10.1006/bbrc.2001.4577
Lowell, 2005, Mitochondrial dysfunction and type 2 diabetes, Science, 307, 384, 10.1126/science.1104343
Maassen, 2004, Mitochondrial diabetes: molecular mechanisms and clinical presentation, Diabetes, 53, S103, 10.2337/diabetes.53.2007.S103
MacDonald, 1990, Insulin release in pancreatic islets by a glycolytic and a Krebs cycle intermediate: contrasting patterns of glyceraldehyde phosphate and succinate, Arch. Biochem. Biophys., 279, 104, 10.1016/0003-9861(90)90468-E
MacLellan, 2005, Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells, Diabetes, 54, 2343, 10.2337/diabetes.54.8.2343
Maechler, 2001, Mitochondrial function in normal and diabetic β-cells, Nature, 414, 807, 10.1038/414807a
Maritim, 2003, Diabetes, oxidative stress, and antioxidants: a review, J. Biochem. Mol. Toxicol., 17, 24, 10.1002/jbt.10058
Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet., 34, 267, 10.1038/ng1180
Nakamura, 1997, Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation, Diabetes, 46, 895, 10.2337/diabetes.46.5.895
Nègre-Salvayre, 1997, A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation, FASEB J., 11, 809, 10.1096/fasebj.11.10.9271366
Nishikawa, 2000, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, 404, 787, 10.1038/35008121
Nishikawa, 2000, The missing link: a single unifying mechanism for diabetic complications, Kidney Int., 58, S26, 10.1046/j.1523-1755.2000.07705.x
Olefsky, 2000, Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists, J. Clin. Invest., 106, 467, 10.1172/JCI10843
Oliveira, 2001, Decreased susceptibility of heart mitochondria from diabetic GK rats to mitochondrial permeability transition induced by calcium/phosphate, Biosci. Rep., 21, 45, 10.1023/A:1010482017540
Oliveira, 2003, Enhanced permeability transition explains the reduced calcium uptake in cardiac mitochondria from streptozotocin-induced diabetic rats, FEBS Lett., 554, 511, 10.1016/S0014-5793(03)01233-X
Oliveira, 2004, Vitamin E or coenzyme Q10 administration are not fully advantageous for heart mitochondrial function in diabetic Goto Kakizaki rats, Mitochondrion, 3, 337, 10.1016/j.mito.2004.02.005
Pacher, 2005, Role of poly(ADP-Ribose) Polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme, Antioxid. Redox Signal., 7, 1568, 10.1089/ars.2005.7.1568
Palmeira, 1999, Higher efficiency of the liver phosphorylative system in diabetic Goto–Kakizaki (GK) rats, FEBS Lett., 458, 103, 10.1016/S0014-5793(99)01144-8
Palmeira, 2001, Enhanced mitochondrial testicular antioxidant capacity in Goto–Kakizaki (GK) diabetic rats: role of coenzyme Q, Am. J. Physiol., 28, C1023, 10.1152/ajpcell.2001.281.3.C1023
Park, 2001, Depletion of mitochondrial DNA alters glucose metabolism in SK-Hep1 cells, Am. J. Physiol.: Endocrinol. Metab., 280, E1007
Park, 2005, Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver, Diabetes, 54, 2514, 10.2337/diabetes.54.9.2514
Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1, Proc. Natl. Acad. Sci. U.S.A., 100, 8466, 10.1073/pnas.1032913100
Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science, 300, 1140, 10.1126/science.1082889
Petersen, 2004, Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes, N. Engl. J. Med., 350, 664, 10.1056/NEJMoa031314
Puigserver, 2003, Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator, Endocr. Rev., 24, 78, 10.1210/er.2002-0012
Ram, 2003, Therapeutic significance of peroxisome proliferator-activated modulators in diabetes, Drugs Today, 39, 609, 10.1358/dot.2003.39.8.799408
Robertson, 2004, Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes, J. Biol. Chem., 279, 42351, 10.1074/jbc.R400019200
Robertson, 1992, Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations, J. Clin. Invest., 90, 320, 10.1172/JCI115865
Robertson, 2003, Glucose toxicity in beta-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection, Diabetes, 52, 581, 10.2337/diabetes.52.3.581
Russell, 2002, High glucose-induced oxidative stress and mitochondrial dysfunction in neurons, FASEB J., 16, 1738, 10.1096/fj.01-1027com
Russell, 2004, Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner, Circ. Res., 94, 525, 10.1161/01.RES.0000117088.36577.EB
Santos, 2001, Brain and liver mitochondria isolated from diabetic Goto–Kakizaki rats shown different susceptibility to induced-oxidative stress, Diabetes/Metab. Res. Rev., 17, 223, 10.1002/dmrr.200
Santos, 2003, Diabetes and mitochondrial oxidative stress: a study using heart mitochondria from the diabetic Goto–Kakizaki rat, Mol. Cell. Biochem., 246, 163, 10.1023/A:1023475022025
Schrauwen, 2001, Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes, Diabetes, 50, 2870, 10.2337/diabetes.50.12.2870
Serradas, 1995, Mitochondrial deoxyribonucleic acid content is specifically decreased in adult, but not fetal, pancreatic islets of the Goto–Kakizaki rat, a genetic model of noninsulin-dependent diabetes, Endocrinology, 136, 5623, 10.1210/en.136.12.5623
Sheu, 1995, Targeting antioxidants to mitochondria: a new therapeutic direction, Biochim. Biophys. Acta, 256
Shimabukuro, 1997, Induction of uncoupling protein-2 mRNA by troglitazone in the pancreatic islets of Zucker diabetic fatty rats, Biochem. Biophys. Res. Commun., 237, 359, 10.1006/bbrc.1997.7140
Shimokawa, 1998, In vivo effects of pioglitazone on uncoupling protein-2 and -3 mRNA levels in skeletal muscle of hyperglycemic KK mice, Biochem. Biophys. Res. Commun., 251, 374, 10.1006/bbrc.1998.9479
Silva, 2000, Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes, Nat. Genet., 26, 336, 10.1038/81649
Skulachev, 1996, Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants, Q. Rev. Biophys., 29, 169, 10.1017/S0033583500005795
Skulachev, 1998, Uncoupling: new approaches to an old problem of bioenergetics, Biochim. Biophys. Acta, 1363, 100, 10.1016/S0005-2728(97)00091-1
Soejima, 1996, Mitochondrial DNA is required for regulation of glucose-stimulated insulin secretion in a mouse pancreatic beta cell line, MIN6, J. Biol. Chem., 271, 26194, 10.1074/jbc.271.42.26194
Soulis-Liparota, 1991, Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat, Diabetes, 40, 1328, 10.2337/diabetes.40.10.1328
Sparks, 2005, A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle, Diabetes, 54, 1926, 10.2337/diabetes.54.7.1926
Starkov, 2003, Regulation of brain mitochondrial H2O2 production by membrane potential and NAD(P)H redox state, J. Neurochem., 68, 1101, 10.1046/j.1471-4159.2003.01908.x
Stayrook, 2005, Regulation of carbohydrate metabolism by the farnesoid X receptor, Endocrinology, 146, 964, 10.1210/en.2004-0965
Stitt, 2004, Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy, Curr. Pharm. Des., 10, 3349, 10.2174/1381612043383124
Suh, 2004, Overexpression of short heterodimer partner recovers impaired glucose-stimulated insulin secretion of pancreatic β-cells overexpressing UCP2, J. Endocrinol., 183, 133, 10.1677/joe.1.05675
Szabo, 2005, Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications, Pharmacol. Res., 52, 60, 10.1016/j.phrs.2005.02.015
Ulrich, 2001, Protein glycation, diabetes, and aging, Recent Prog. Horm. Res., 56, 1, 10.1210/rp.56.1.1
Vincent, 2004, Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death, Diabetes, 53, 726, 10.2337/diabetes.53.3.726
Virbasius, 1994, Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis, Proc. Natl. Acad. Sci. U.S.A., 91, 1309, 10.1073/pnas.91.4.1309
Voziyan, 2005, Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage, Cell. Mol. Life Sci., 62, 1671, 10.1007/s00018-005-5082-7
Woon, 2005, Poly(ADP-ribose)polymerase inhibition—where now?, Curr. Med. Chem., 12, 2373, 10.2174/0929867054864778
Wu, 1999, Mechanisms controlling mitochondrial biogenesis and function through the thermogenic coactivator PGC-1, Cell, 98, 115, 10.1016/S0092-8674(00)80611-X
Wu, 2001, Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis, Biochem. J., 353, 245, 10.1042/0264-6021:3530245
Yan, 1994, Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins, J. Biol. Chem., 269, 9889, 10.1016/S0021-9258(17)36966-1